Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas. Academic Article uri icon

Overview

abstract

  • BACKGROUND: There is a sparsity of data evaluating outcomes of patients with Liver Imaging Reporting and Data System (LI-RADS) (LR)-M lesions. PURPOSE: To compare overall survival (OS) and progression free survival (PFS) between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) meeting LR-M criteria and to evaluate factors associated with prognosis. STUDY TYPE: Retrospective. SUBJECTS: Patients at risk for HCC with at least one LR-M lesion with histologic diagnosis, from 8 academic centers, yielding 120 patients with 120 LR-M lesions (84 men [mean age 62 years] and 36 women [mean age 66 years]). FIELD STRENGTH/SEQUENCE: A 1.5 and 3.0 T/3D T1 -weighted gradient echo, T2 -weighted fast spin-echo. ASSESSMENT: The imaging categorization of each lesion as LR-M was made clinically by a single radiologist at each site and patient outcome measures were collected. STATISTICAL TESTS: OS, PFS, and potential independent predictors were evaluated by Kaplan-Meier method, log-rank test, and Cox proportional hazard model. A P value of <0.05 was considered significant. RESULTS: A total of 120 patients with 120 LR-M lesions were included; on histology 65 were HCC and 55 were iCCA. There was similar median OS for patients with LR-M HCC compared to patients with iCCA (738 days vs. 769 days, P = 0.576). There were no significant differences between patients with HCC and iCCA in terms of sex (47:18 vs. 37:18, P = 0.549), age (63.0 ± 8.4 vs. 63.4 ± 7.8, P = 0.847), etiology of liver disease (P = 0.202), presence of cirrhosis (100% vs. 100%, P = 1.000), tumor size (4.73 ± 3.28 vs. 4.75 ± 2.58, P = 0.980), method of lesion histologic diagnosis (P = 0.646), and proportion of patients who underwent locoregional therapy (60.0% vs. 38.2%, P = 0.100) or surgery (134.8 ± 165.5 vs. 142.5 ± 205.6, P = 0.913). Using multivariable analysis, nonsurgical compared to surgical management (HR, 4.58), larger tumor size (HR, 1.19), and higher MELD score (HR, 1.12) were independently associated with worse OS. DATA CONCLUSION: There was similar OS in patients with LR-M HCC and LR-M iCCA, suggesting that LR-M imaging features may more closely reflect patient outcomes than histology. EVIDENCE LEVEL: 3 TECHNICAL EFFICACY: Stage 5.

authors

  • Kierans, Andrea Siobhan
  • Lafata, Kyle J
  • Ludwig, Daniel R
  • Burke, Lauren M B
  • Chernyak, Victoria
  • Fowler, Kathryn J
  • Fraum, Tyler J
  • McGinty, Katrina A
  • McInnes, Matthew D F
  • Mendiratta-Lala, Mishal
  • Cunha, Guilherme Moura
  • Allen, Brian C
  • Hecht, Elizabeth
  • Jaffe, Tracy A
  • Kalisz, Kevin R
  • Ranathunga, Damithri S
  • Wildman-Tobriner, Benjamin
  • Cardona, Diana M
  • Aslam, Anum
  • Gaur, Sonia
  • Bashir, Mustafa R

publication date

  • May 5, 2022

Research

keywords

  • Bile Duct Neoplasms
  • Carcinoma, Hepatocellular
  • Cholangiocarcinoma
  • Liver Neoplasms

Identity

Scopus Document Identifier

  • 85129332021

Digital Object Identifier (DOI)

  • 10.1002/jmri.28218

PubMed ID

  • 35512243

Additional Document Info

volume

  • 57

issue

  • 1